Company Profile
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows:
- solutions and products for scientific and biotechnological research (45.7%);
- pharmaceutical products (36%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.;
- performance materials for the electronics industry (18.3%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc.
Net sales are distributed geographically as follows: Germany (5.4%), Switzerland (2%), Europe (21.4%), China (14.7%), Asia/Pacific (21%), the United States (26.1%), North America (1.3%), Latin America (5%), Middle East and Africa (3.1%).
- solutions and products for scientific and biotechnological research (45.7%);
- pharmaceutical products (36%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.;
- performance materials for the electronics industry (18.3%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc.
Net sales are distributed geographically as follows: Germany (5.4%), Switzerland (2%), Europe (21.4%), China (14.7%), Asia/Pacific (21%), the United States (26.1%), North America (1.3%), Latin America (5%), Middle East and Africa (3.1%).
Source: Cofisem - Last Update: 2023-05-22
Key Executives
| Chairman of the Management Board | |
| Member of the Management Board | |
| Member of the Management Board | |
| Member of the Management Board | |
| Member of the Management Board | |
| Chief Financial Officer | |
| Investor Relations Director |
Source: Cofisem - Last Update: 2022-07-06
Key Figures
| Millenium | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Net sales | 22,232,000 | 19,687,000 | 17,534,000 | 16,152,000 | 14,836,000 |
| Income from ordinary activities | 22,232,000 | 19,687,000 | 17,534,000 | 16,152,000 | 14,836,000 |
| Operating income | 4,474,000 | 4,179,000 | 2,985,000 | 2,120,000 | 1,727,000 |
| Cost of financial indebtedness net | 164,000 | 226,000 | 348,000 | 364,000 | 213,000 |
| Equity-accounted companies contribution to income | |||||
| Net profit from discontinued activities | 0 | 28,000 | 2,303,000 | ||
| Net income | 3,339,000 | 3,065,000 | 1,994,000 | 1,324,000 | 3,396,000 |
| Net income (Group share) | 3,326,000 | 3,055,000 | 1,987,000 | 1,320,000 | 3,374,000 |
| Fiscal year end | 12.22 | 12.21 | 12.2 | 12.19 | 12.18 |
| Length of fiscal year (month) | 12 | 12 | 12 | 12 | 12 |
| Currency & Unit | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands |
| Account Standards |
Source: Cofisem - Last Update: 2023-05-22
Shareholder information
| BlackRock, Inc. | |
| Crédit Agricole S.A. | |
| Deutsche Bank AG | |
| State Street Corporation | |
| Sun Life Financial |
Source: Cofisem - Last Update: 2023-05-22
Address
Merck KGaA
Frankfurter Strasse 250
DE-64293 Darmstadt, Hessen
Germany
Phone number: +49 (0)6151 72 0
Fax: +49 (0)6151 72 2000
https://www.merckgroup.com/de
Source: Cofisem - Last Update: 2023-05-22
Please contact MyQuestion.Italy@euronext.com for Company Profile support.